Laboratoires Urgo

Societe De Developpement Et De Recherche Industrielle

Urgo Recherche Innovation Et Developpement

Blue Light Photobiomodulation Gdbr

Universitat Heidelberg

Université D'evry-Val-d'essonne

Centre D'etude Des Cellules Souches

Adhara

Marielle Bouschbacher

Norbert Gretz

Laurent Apert

Christelle Laurensou

Julien Steinbrunn

Fabiola Arpino

Anja Becker

Anna Klapczynski

Natalia Kuch

Julien Denis Marie Steinbrunn

Sophie Domingues

Louis Lavigne

Guillaume Olive

Christine Baldeshi

Andreas Hullen

Sophie Clement

Yifei Mu

The invention is directed to a light source device comprising a light emitting element for emitting a blue light having a wavelength ranging from 435 to 500 nm, the light source device being configured to provide the blue light to at least one cell at a transmitted fluence ranging from 0.01 to 18. J/cmto promote or induce growth and proliferation of the cell and wherein the light emitting element has a power density ranging from 0.05 to 30 mW/cm. The invention is also directed to a light source assembly comprising a product adapted to be in contact with the skin or a wound and a light source device connected to the product for providing blue light to at least one skin cell, preferably of the wound.

Blue light photobiomodulation

The present invention relates to a compound selected among the synthetic polysulphated oligosaccharides having 1 to 4 ose units and the salts and complexes thereof to be used for the treatment of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars. Said use is preferred in particular in patients that have a predisposition to developing hypertrophic, retractile or atrophic scars. According to a second aspect, the invention also relates to said compound for the use thereof in order to inhibit the differentiation of fibroblasts into myofibroblasts during the cicatrisation of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars.

Use of oligosaccharide compounds for the prevention and treatment of pathological scars

The present invention relates to a topical composition, in particular a cosmetic and/or dermatological composition, to be used for preventing and/or treating stretch marks, including, in a physiologically acceptable medium, an effective amount of at least one synthetic polysulfated oligosaccharide having 1 to 4 glycose units, the salts thereof, and/or the derivatives thereof. The invention also relates to a cosmetic method, in particular for treating stretch marks, including at least one step of applying said composition to the skin.

Cosmetic and/or dermatological use of oligosaccharide compounds for preventing and treating stretch marks

Growing community of inventors

Chambolle-Musigny, France

Marielle Bouschbacher